Vanguard Group’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-499,932
| Closed | -$136K | – | 4598 |
|
|
2022
Q3 | $136K | Buy |
499,932
+186,229
| +59% | +$50.7K | ﹤0.01% | 4466 |
|
|
2022
Q2 | $110K | Sell |
313,703
-7,900
| -2% | -$2.77K | ﹤0.01% | 4539 |
|
|
2022
Q1 | $218K | Sell |
321,603
-404,761
| -56% | -$274K | ﹤0.01% | 4525 |
|
|
2021
Q4 | $1.68M | Sell |
726,364
-4,208
| -0.6% | -$9.72K | ﹤0.01% | 4103 |
|
|
2021
Q3 | $3.35M | Buy |
730,572
+14,790
| +2% | +$67.7K | ﹤0.01% | 3872 |
|
|
2021
Q2 | $3.18M | Sell |
715,782
-83,943
| -10% | -$373K | ﹤0.01% | 3814 |
|
|
2021
Q1 | $5.82M | Buy |
799,725
+12,247
| +2% | +$89.2K | ﹤0.01% | 3452 |
|
|
2020
Q4 | $6.01M | Buy |
787,478
+453,636
| +136% | +$3.46M | ﹤0.01% | 3276 |
|
|
2020
Q3 | $3.03M | Sell |
333,842
-2,325
| -0.7% | -$21.1K | ﹤0.01% | 3364 |
|
|
2020
Q2 | $2.84M | Buy |
336,167
+19,220
| +6% | +$163K | ﹤0.01% | 3328 |
|
|
2020
Q1 | $1.57M | Buy |
316,947
+416
| +0.1% | +$2.06K | ﹤0.01% | 3362 |
|
|
2019
Q4 | $2.28M | Sell |
316,531
-1,805
| -0.6% | -$13K | ﹤0.01% | 3413 |
|
|
2019
Q3 | $3.44M | Buy |
318,336
+40,477
| +15% | +$438K | ﹤0.01% | 3272 |
|
|
2019
Q2 | $3.61M | Buy |
277,859
+7,588
| +3% | +$98.6K | ﹤0.01% | 3276 |
|
|
2019
Q1 | $2.67M | Buy |
270,271
+54,370
| +25% | +$537K | ﹤0.01% | 3358 |
|
|
2018
Q4 | $2.25M | Buy |
+215,901
| New | +$2.25M | ﹤0.01% | 3339 |
|